Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

2.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.3K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

1.2K
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.2K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

807
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
807
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

1.3K
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
1.3K
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

28
Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
28
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

38
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant...
38

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longterm results of esophageal myotomy for achalasia.

Journal of the American College of Surgeons·2001
Same author

Operative treatment for chronic pancreatitis pain.

Journal of the American College of Surgeons·2001
Same author

A personal experience with pancreatic and duodenal neuroendocrine tumors.

Journal of the American College of Surgeons·1999
Same author

New look at epiphrenic diverticula.

World journal of surgery·1999
Same author

Glucagon facilitates end-to-end pancreaticojejunostomy.

Journal of the American College of Surgeons·1997
Same author

Parietal cell vagotomy performed with fundoplication for esophageal reflux.

American journal of surgery·1997

Related Experiment Video

Updated: May 5, 2026

Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis
10:41

Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis

Published on: December 15, 2023

3.4K

Operations for duodenal ulcer disease.

P H Jordan1

  • 1Department of Surgery, Baylor College of Medicine, Houston, Texas 77030.

Annual Review of Medicine
|January 1, 1989
PubMed
Summary

Parietal cell vagotomy, a surgical approach for duodenal ulcers, offers a low operative mortality rate of 0.26% and minimal side effects. This procedure is increasingly favored by surgeons for effectively treating ulcers without recurrence.

Area of Science:

  • Gastroenterology
  • Surgical Innovation
  • Peptic Ulcer Disease Management

Background:

  • Surgical intervention for duodenal ulcers is reserved for complicated cases or non-responders to medical therapy.
  • Traditional surgical methods include gastric drainage, resection, denervation, or combinations thereof.
  • Historical surgical goals focused on preventing ulcer recurrence, while current aims include cure without recurrence or physiological compromise.

Purpose of the Study:

  • To evaluate the efficacy and safety of parietal cell vagotomy without a drainage procedure for duodenal ulcer treatment.
  • To assess the long-term outcomes, including recurrence rates and side effects, of this surgical technique.

Main Methods:

  • Intensive study of parietal cell vagotomy over 19 years.

More Related Videos

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors
03:37

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

Published on: December 20, 2024

1.0K
Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions
03:57

Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions

Published on: April 28, 2026

Related Experiment Videos

Last Updated: May 5, 2026

Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis
10:41

Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis

Published on: December 15, 2023

3.4K
Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors
03:37

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

Published on: December 20, 2024

1.0K
Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions
03:57

Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions

Published on: April 28, 2026

  • Analysis of operative mortality, ulcer recurrence rates, and patient-reported side effects.
  • Comparison with historical and contemporary surgical procedures for duodenal ulcers.

    • Main Results:

    • Parietal cell vagotomy demonstrates an operative mortality rate of 0.26%.
    • Recurrence rates for parietal cell vagotomy range from 4% to 11%.
    • The procedure is associated with virtually no significant undesirable sequelae or altered gastric physiology.

    Conclusions:

    • Parietal cell vagotomy without drainage is a highly effective and safe surgical option for duodenal ulcers.
    • Its favorable outcome profile, including low mortality and minimal side effects, has led to its adoption as a preferred procedure by many surgeons.